This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignees: Pfizer Corporation, Astellas Pharma Gmbh, Raqualia Pharma Inc.. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chita-gun, JP (2010)
- Aichi-ken, JP (2009 - 2011)
- Tokyo, JP (2016)
Company Filing History:
3 out of 4,486 
2 out of 424 
1 out of 47 Years Active: 2009-2016
Title: Innovation and Contributions of Takeshi Hanazawa in Pharmaceutical Patents
Introduction
Takeshi Hanazawa is a notable inventor located in Aichi-ken, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of three patents that focus on novel compounds with potential therapeutic applications. His work emphasizes the importance of innovative approaches in drug development.
Latest Patents
Takeshi's latest patents include "Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists." This invention provides a compound with a complex formula designed to target the VR1 receptor, which is implicated in pain sensation. The specificity and versatility of the compounds are highlighted by multiple substituents that can enhance their pharmacological properties. His other patent on the same subject also involves similar compounds, showcasing his dedication to advancing medical science through innovative chemical structures.
Career Highlights
Currently, Takeshi Hanazawa is working with Pfizer Corporation, a leading global pharmaceutical company known for its research and development efforts. His role in this prestigious organization underscores his expertise and the trust placed in him by one of the largest players in the industry. Throughout his career, he has continually aimed to discover and develop compounds that can address unmet medical needs.
Collaborations
During his tenure at Pfizer, Takeshi has collaborated with several esteemed colleagues, including Misato Hirano and Tadashi Inoue. These partnerships have fostered an environment of creativity and innovation, enabling the team to leverage their diverse expertise for the advancement of their projects. Their collective efforts have been instrumental in driving forward significant research initiatives.
Conclusion
In summary, Takeshi Hanazawa’s contributions to the pharmaceutical industry through his inventive patents reflect a commitment to innovation and collaboration. His work exemplifies the critical role that inventors play in developing solutions that can lead to transformative therapies, ultimately benefiting society as a whole.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile